Keryx Investor Sues In Chancery For Akebia Merger Records
A Keryx Biopharmaceuticals Inc. investor sued Monday in Delaware Chancery Court for access to company records on a pending merger with Akebia Therapeutics Inc., saying the documents are needed to investigate...To view the full article, register now.
Already a subscriber? Click here to view full article